- Poznan Grunwaldzka
- Hybrid
- £410,250 – £683,750 pa
- Director
Provides medical and scientific leadership in safety evaluation and risk management for oncology assets in clinical development, interpreting safety data, escalating signals and delivering evidence-based benefit-risk recommendations. Leads Safety Review Teams and cross-functional matrix groups, representing Safety to governance committees and regulatory authorities. Hybrid role based in the UK, Belgium, Poland or Italy.